← Back to Vaccine Database

BBIBP-CorV

Inactivated vaccine · VDDBV0112

Target & Classification

SARS-CoV-2SARS-CoV-2
Inactivated vaccine
COVID-19
ApprovedPhase 4 reached

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials14

Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT04998240 Phase 2COVID-19
NCT05172193 Phase 2COVID-19
NCT05162482 Phase 2COVID-19
NCT04560881 Phase 3COVID-19
NCT04917523 Phase 3COVID-19
NCT04510207 Phase 3COVID-19
NCT04984408 Phase 3COVID-19
NCT04863638 ApprovedCOVID-19
NCT05065879 ApprovedCOVID-19
NCT05075070 ApprovedCOVID-19
NCT05075083 ApprovedCOVID-19
NCT05104333 ApprovedCOVID-19
NCT05105295 ApprovedCOVID-19
NCT05104216 ApprovedCOVID-19